Skip to main content
Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.420
-0.020 (-1.39%)
At close: Apr 30, 2024, 4:00 PM
1.431
+0.011 (0.77%)
After-hours: Apr 30, 2024, 4:46 PM EDT

Spero Therapeutics Revenue

In the year 2023, Spero Therapeutics had annual revenue of $103.78M with 93.95% growth. Revenue in the quarter ending December 31, 2023 was $73.52M with 54.98% year-over-year growth.

Revenue (ttm)
$103.78M
Revenue Growth
+93.95%
P/S Ratio
0.75
Revenue / Employee
$2,256,109
Employees
46
Market Cap
76.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023103.78M50.27M93.95%
Dec 31, 202253.51M35.25M193.10%
Dec 31, 202118.26M8.93M95.67%
Dec 31, 20209.33M-8.82M-48.59%
Dec 31, 201918.15M14.18M357.56%
Dec 31, 20183.97M1.99M100.40%
Dec 31, 20171.98M1.64M490.75%
Dec 31, 2016335.00K--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SPRO News

More News